ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,680 | +74.0% | 2,000 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $23,950 | +27.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $18,820 | +18.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $15,920 | -0.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | +14.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | -41.7% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $24,000 | +4.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $23,000 | -8.0% | 1,000 | -33.7% | 0.00% | 0.0% |
| Q3 2021 | $25,000 | -32.4% | 1,508 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $37,000 | -5.1% | 1,508 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $39,000 | -51.9% | 1,508 | 0.0% | 0.00% | -57.1% |
| Q4 2020 | $81,000 | +30.6% | 1,508 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $62,000 | +158.3% | 1,508 | +201.6% | 0.01% | +133.3% |
| Q2 2020 | $24,000 | +14.3% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $21,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |